China & Merck & Co.

China: China is the focus of the investigation due to its clinical trial environment, which is described as having questionable ethics and potential links to its military. The investigation highlights U.S. concerns about China's biotechnology ecosystem and its alleged human rights abuses in China — Xinjiang.

Merck & Co.: Merck & Co. is under investigation by the United States — House Select Committee on the Chinese Communist Party for its clinical trials in China, particularly in China — Xinjiang and at military hospitals, raising concerns about national security and ethics. This exposes Merck & Co. to potential reputational damage and regulatory scrutiny.